Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Katsuhiko Kadota"'
Autor:
Masaki Ishihara, Satoshi Abe, Koichi Imaoka, Tomonori Nakagawa, Katsuhiko Kadota, Hiroaki Oguro, Hideto Nakajima, Shuhei Yamaguchi, Atsushi Nagai
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 12, p1823-1827, 5p
Autor:
Mitsuru Wakita, Mayumi Idei, Kaori Saito, Yuki Horiuchi, Kotoko Yamatani, Suzuka Ishikawa, Takamasa Yamamoto, Gene Igawa, Masanobu Hinata, Katsuhiko Kadota, Taro Kurosawa, Sho Takahashi, Takumi Saito, Shigeki Misawa, Chihiro Akazawa, Toshio Naito, Takashi Miida, Kazuhisa Takahashi, Tomohiko Ai, Yoko Tabe
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246536 (2021)
We examined the usefulness of five COVID-19 antibody detection tests using 114 serum samples at various time points from 34 Japanese COVID-19 patients. We examined Elecsys Anti-SARS-CoV-2 from Roche, and four immunochromatography tests from Hangzhou
Externí odkaz:
https://doaj.org/article/e9f4824746a743bdbc5c9aaf99c65e82
Autor:
Katsuhiko Kadota, Keiichi Onoda, Satoshi Abe, Chizuko Hamada, Shingo Mitaki, Hiroaki Oguro, Atsushi Nagai, Hajime Kitagaki, Shuhei Yamaguchi
Publikováno v:
Life, Vol 11, Iss 12, p 1411 (2021)
Distinguishing progressive supranuclear palsy (PSP) from multiple system atrophy (MSA) in the early clinical stages is challenging; few sensitive and specific biomarkers are available for their differential diagnosis. Resting-state functional magneti
Externí odkaz:
https://doaj.org/article/026fcd358c8b4b90abb6a5f7cefa4d6c
Autor:
Toshiaki Iba, Jerrold H. Levy, Koichiro Aihara, Katsuhiko Kadota, Hiroshi Tanaka, Koichi Sato, Isao Nagaoka
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 1, p 176 (2020)
(1) Background: The endothelial glycocalyx is a primary target during the early phase of sepsis. We previously reported a newly developed recombinant non-fucosylated antithrombin has protective effects in vitro. We further evaluated the effects of th
Externí odkaz:
https://doaj.org/article/7e9988bb5d43434bb1150bdb435c520b
Autor:
Isao Nagaoka, Koichiro Aihara, Koichi Sato, Hiroshi Tanaka, Toshiaki Iba, Katsuhiko Kadota, Jerrold H. Levy
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 1
International Journal of Molecular Sciences, Vol 22, Iss 176, p 176 (2021)
Volume 22
Issue 1
International Journal of Molecular Sciences, Vol 22, Iss 176, p 176 (2021)
(1) Background: The endothelial glycocalyx is a primary target during the early phase of sepsis. We previously reported a newly developed recombinant non-fucosylated antithrombin has protective effects in vitro. We further evaluated the effects of th
Autor:
Toshio Naito, Mayumi Idei, Kazuhisa Takahashi, Shigeki Misawa, Katsuhiko Kadota, Yoko Tabe, Chihiro Akazawa, Sho Takahashi, Kaori Saito, Kotoko Yamatani, Gene Igawa, Takumi Saito, Taro Kurosawa, Yuki Horiuchi, Masanobu Hinata, Tomohiko Ai, Takashi Miida, Suzuka Ishikawa, Mitsuru Wakita, Takamasa Yamamoto
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246536 (2021)
PLoS ONE
PLoS ONE
We examined the usefulness of five COVID-19 antibody detection tests using 114 serum samples at various time points from 34 Japanese COVID-19 patients. We examined Elecsys Anti-SARS-CoV-2 from Roche, and four immunochromatography tests from Hangzhou
Autor:
Yukie Nakadera, Tomonori Nakagawa, Satoshi Abe, Katsuhiko Kadota, Shuhei Yamaguchi, Shingo Mitaki, Hiroyuki Takayoshi
Publikováno v:
Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics. 52:425-428
We herein describe the case of a 90-year-old man. He had been treated for type II diabetes mellitus for over twenty years. One day he noticed weakness in the bilateral upper limbs. The next morning the symptoms extended to the bilateral lower limbs.
Publikováno v:
International Journal of Clinical Medicine. :885-889
Background: Apathy occurs frequently in patients with Parkinson’s disease (PD), and has a negative impact on activities of daily living through loss of motivation. Pramipexole (PPX), which shows preferential affinity for D3 dopamine receptor in the
Publikováno v:
Nihon Naika Gakkai Zasshi. 103:486-491
Publikováno v:
Intensive Care Medicine Experimental
Background The beneficial effects of heparin in the treatment of severe sepsis, septic shock, and sepsis-associated disseminated intravascular coagulation (DIC) have recently been reported. However, the mechanisms underlying the therapeutic benefits